Global Duchenne Muscular Dystrophy Treatment Market Report 2023 - Cognitive Market Research

Data has been removed due to this being a sample, to access the paid version please contact us!
Global Duchenne Muscular Dystrophy Treatment Market Report 2023
2
Who Do
We Serve
Company
Strategy
Who We Are
What Do
We Do
Cognitive is a global leader
in research market business
and consulting. Publishing
more than a 100 research
studies every month, we
serve more than half of the
Fortune 500 companies
across the world. We, at
CMR, can help you with
multi-client reports,
company data profiles,
bases, procurement
intelligence, and custom
research services.
We at CMR, cover almost all
business verticals, including
chemicals, advanced materials,
agriculture, biotechnology,
industrial automation, medical
devices, mining, minerals,
metals, packaging,
pharmaceuticals, electronics,
telecommunications, IT,
aerospace and defense, food
and beverage and construction,
and building, and energy and
power.
We are not only a publisher of the
syndicate report but we also
provide the industry database and
respective topic's consultation. We,
at CMR, make all efforts to ensure
that our reports cover all aspects of
our industry. The Report
Customization along with a
dedicated research analyst access
puts us in a business category
where none of our competitors are
present.
We are the trusted business
partners to the world's leading
corporations, governments, and
institutions/universities. We also
have 1000+ client organizations
across the private, public and
social sectors. Client list ranges
from small and start-up
businesses to fortune 500
companies. Our client base
extends across Asia, North South
America, America, Europe,
Australia and Africa to know
more please refer to our cilentele
and testimony page on the
website.
COGNITIVE is the global leader in market research and business
consulting. We have been publishing more than a 250 research
studies every month we serve more than half of the Fortune 500
companies across the globe. We at COGNITIVE can help you with
multi-client reports, company profiles, data bases, procurement
intelligence and custom research services.
We at COGNITIVE cover almost all business verticals including chemicals,
advanced materials, agriculture, biotechnology, industrial automation,
medical devices, mining, minerals, metals, packaging, pharmaceuticals,
electronics, telecommunications, IT, aerospace and defense, food and
beverage and construction and building, and energy and power. While most
syndicated reports are standardized, we at COGNITIVE make all efforts to
ensure that our reports cover all aspects of the industry giving our customers
a holistic view of the industry COGNITIVE is backed by more than 120 analysts
and over 3000 industry experts, consultants and freelancers globally. We cover
more than 15 industry sectors in over 100 countries around the world. Please
feel free to let us know in case you need a deeper dive in any of the sections
mentioned in the report and one of our consultants will be happy to respond
back to you. © 2023 COGNITIVE Market Research.
About
Cognitive
Market Research

3
The base year for the calculation is 2022 and 2018 to 2022 will be historical period. At the same time, data
for the year 2023 will be an estimated one while the forecasted data will be from year 2023 to 2030.
Historical Years
From 2018
Till 2022
Base Year
2022
Forecast Period
From 2023
Till 2030
Primary Research Methodology
Secondary Research Methodology
Market Size Estimation Methodology
Data Triangulation
Business Segment/ Overview:
Investment in Research and Development
Recent Developments:
Business Strategy
SWOT Analysis
Key Drivers, Restraints and Opportunities
Market Attractiveness Analysis for Each Segment and Region
PESTEL Analysis
Porter 5 Force’s Analysis
Value Chain Analysis
North America (United States, Canada, Mexico)
Europe (UK, France, Germany, Italy, Russia, Spain)
Asia Pacific (China, Japan, Korea, India, South East Asia)
South America (Brazil, Argentina, Colombia)
Middle East & Africa (GCC, Egypt, South Africa, Nigeria, Turkey)
1 2
4
3

4
Product Type
• NSAIDs
• Corticosteroids
• Other Products
Distribution Channel Therapy
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Mutation
Suppression
• Exon Skipping
Approach
• Others Therapies
Regions
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

5
1.1 Research Methodology...............................................................................................26
1.1.1 Primary Research........................................................................................................ 27
1.1.2 Modes of Primary Research:....................................................................................... 28
1.2 Secondary Research Methodology:.............................................................................28
1.3 Market Estimation......................................................................................................29
1.3.1 Top-Down Method ..................................................................................................... 30
1.3.2 Bottom-Up Method .................................................................................................... 30
1.3.3 Data Triangulation ...................................................................................................... 31
1.4 Questionnaire ............................................................................................................32
2.1 Global Duchenne Muscular Dystrophy Treatment Industry Introduction......................33
2.2 Objectives of the Study...............................................................................................34
2.3 USP of the Report.......................................................................................................34
2.4 Who is this report for?................................................................................................35
2.5 Regional Fragmentation .............................................................................................35
2.6 Report Duration .........................................................................................................36
2.7 List of Stakeholders ....................................................................................................36
3.1 Global Duchenne Muscular Dystrophy Treatment Market, 2018 – 2030, (USD
Million)......................................................................................................................37
3.2 Global Duchenne Muscular Dystrophy Treatment Value, Absolute &
Opportunity Analysis..................................................................................................37
3.3 Global Duchenne Muscular Dystrophy Treatment Market Y-o-Y Growth
Projection by Region (2023 - 2030)..............................................................................38
3.4 Global Duchenne Muscular Dystrophy Treatment Market: Snapshot ...........................39
4.1 Product Overview and Scope of Duchenne Muscular Dystrophy Treatment
Market.......................................................................................................................41
4.2 Global Duchenne Muscular Dystrophy Treatment Revenue Market by Regions
(2018-2030)................................................................................................................42
4.2.1 North America Duchenne Muscular Dystrophy Treatment Status and Prospect
(2018-2030) ................................................................................................................ 43

6
4.2.1.1 North America Duchenne Muscular Dystrophy Treatment Value,
Absolute & Opportunity Analysis ....................................................................43
4.2.2 Europe Duchenne Muscular Dystrophy Treatment Status and Prospect (2018-
2030) .......................................................................................................................... 44
4.2.2.1 Europe Duchenne Muscular Dystrophy Treatment Value, Absolute &
Opportunity Analysis .......................................................................................44
4.2.3 Asia Pacific Duchenne Muscular Dystrophy Treatment Status and Prospect
(2018-2030) ................................................................................................................ 45
4.2.3.1 Asia Pacific Duchenne Muscular Dystrophy Treatment Value,
4.2.4 Latin America Duchenne Muscular Dystrophy Treatment Status and Prospect
(2018-2030) ................................................................................................................ 46
4.2.4.1 Latin America Duchenne Muscular Dystrophy Treatment Value,
4.2.5 Middle East and Africa Duchenne Muscular Dystrophy Treatment Status and
Prospect (2018-2030).................................................................................................. 47
4.2.5.1 Middle East and Africa Duchenne Muscular Dystrophy Treatment
Value, Absolute & Opportunity Analysis .........................................................47
4.3 Global Duchenne Muscular Dystrophy Treatment Market Size (2018-2030) .................48
4.3.1 Global Duchenne Muscular Dystrophy Treatment Revenue Status and Outlook
(2018-2030) ................................................................................................................ 48
5.1 Global Duchenne Muscular Dystrophy Treatment Revenue and Share by
Manufacturers (2018-2022) ........................................................................................49
5.2 Global Duchenne Muscular Dystrophy Treatment Mergers and Acquisition
Analysis/ Top Winning Strategies/ New Launches Analysis ..........................................51
5.3 Company Categorization.............................................................................................52
5.4 Top Winning Strategies, by Manufacturers (2018-2022)...............................................53
6.1 Overall Company’s Disclosure Score............................................................................54
7.1 Global Duchenne Muscular Dystrophy Treatment Market – COVID – 19 Impact
Analysis .....................................................................................................................55
7.1.1 Influencing Factors...................................................................................................... 56
7.1.2 Forecast Assumptions................................................................................................. 56
7.1.3 Impact of COVID-19 on Global Duchenne Muscular Dystrophy Treatment
Market........................................................................................................................ 57

7
7.1.4 Consumer Buying Behavior on Global Duchenne Muscular Dystrophy
Treatment Market ...................................................................................................... 57
8.1 Market Drivers...........................................................................................................58
8.1.1 Drivers for Duchenne Muscular Dystrophy Treatment Market: Impact Analysis ......... 58
8.2 Market Restraints.......................................................................................................59
8.2.1 Restraints for Duchenne Muscular Dystrophy Treatment Market: Impact
Analysis ...................................................................................................................... 59
8.3 Opportunity ...............................................................................................................60
8.4 Market Trends............................................................................................................60
8.5 Technological Road Map.............................................................................................61
8.6 PESTEL Analysis for Duchenne Muscular Dystrophy Treatment Market........................62
8.6.1 Political....................................................................................................................... 62
8.6.2 Economic .................................................................................................................... 62
8.6.3 Social .......................................................................................................................... 63
8.6.4 Technological.............................................................................................................. 63
8.6.5 Legal ........................................................................................................................... 63
8.6.6 Environmental ............................................................................................................ 63
8.7 Porter’s Five Forces Analysis for Duchenne Muscular Dystrophy Treatment
Market.......................................................................................................................64
8.7.1 Power of Suppliers...................................................................................................... 65
8.7.2 Threat of Substitutes .................................................................................................. 66
8.7.3 Potential of New Entrants into an Industry................................................................. 67
8.7.4 Power of Customers.................................................................................................... 68
8.7.5 Competition in the Industry........................................................................................ 69
8.8 Product Life Cycle of Duchenne Muscular Dystrophy Treatment Market ......................70
8.9 Market Attractiveness Analysis...................................................................................71
8.9.1 Market Attractiveness Analysis by Product Type Segment ......................................... 71
8.9.2 Market Attractiveness Analysis by Application Segment ............................................ 72
9.1 Patent Analysis...........................................................................................................73

8
10.1 Global Duchenne Muscular Dystrophy Treatment Revenue and Market Share
(%) by Product Type (2018-2030) ................................................................................74
10.1.1 NSAIDs........................................................................................................................ 75
10.1.1.1 NSAIDs Duchenne Muscular Dystrophy Treatment Value, Absolute &
Opportunity Analysis .......................................................................................75
10.1.1.2 Duchenne Muscular Dystrophy Treatment Market for NSAIDs, by
Country (2021 Vs 2024)...................................................................................76
10.1.2 Corticosteroids ........................................................................................................... 77
10.1.2.1 Corticosteroids Duchenne Muscular Dystrophy Treatment Value,
10.1.2.2 Duchenne Muscular Dystrophy Treatment Market for
Corticosteroids, by Country (2021 Vs 2024)....................................................78
10.1.3 Other Products ........................................................................................................... 79
10.1.3.1 Other Products Duchenne Muscular Dystrophy Treatment Value,
10.1.3.2 Duchenne Muscular Dystrophy Treatment Market for Other
Products, by Country (2021 Vs 2024) ..............................................................80
(%) by Distribution Channel (2018-2030).....................................................................81
11.1.1 Hospital Pharmacies ................................................................................................... 82
11.1.1.1 Hospital Pharmacies Duchenne Muscular Dystrophy Treatment
11.1.1.2 Duchenne Muscular Dystrophy Treatment Market for Hospital
Pharmacies, by Country (2021 Vs 2024)..........................................................83
11.1.2 Retail Pharmacies ....................................................................................................... 84
11.1.2.1 Retail Pharmacies Duchenne Muscular Dystrophy Treatment Value,
11.1.2.2 Duchenne Muscular Dystrophy Treatment Market for Retail
11.1.3 Online Pharmacies...................................................................................................... 86
11.1.3.1 Online Pharmacies Duchenne Muscular Dystrophy Treatment Value,
11.1.3.2 Duchenne Muscular Dystrophy Treatment Market for Online
(%) by Therapy (2018-2030)........................................................................................88
12.1.1 Mutation Suppression ................................................................................................ 89

9
12.1.1.1 Mutation Suppression Duchenne Muscular Dystrophy Treatment
12.1.1.2 Duchenne Muscular Dystrophy Treatment Market for Mutation
Suppression, by Country (2021 Vs 2024).........................................................90
12.1.2 Exon Skipping Approach ............................................................................................. 91
12.1.2.1 Exon Skipping Approach Duchenne Muscular Dystrophy Treatment
12.1.2.2 Duchenne Muscular Dystrophy Treatment Market for Exon Skipping
Approach, by Country (2021 Vs 2024).............................................................92
12.1.3 Others Therapies ........................................................................................................ 93
12.1.3.1 Others Therapies Duchenne Muscular Dystrophy Treatment Value,
12.1.3.2 Duchenne Muscular Dystrophy Treatment Market for Others
Therapies, by Country (2021 Vs 2024).............................................................94
13.1 ITALFARMACO S.p.A...................................................................................................96
13.1.1 ITALFARMACO S.p.A Basic Information, Manufacturing Base, SalesArea and
its Competitors ........................................................................................................... 96
13.1.2 Business Segment/ Overview:..................................................................................... 97
13.1.3 Financials.................................................................................................................... 98
13.1.4 Investment in Research and Development.................................................................. 99
13.1.5 Duchenne Muscular Dystrophy Treatment Product Types Specification: .................. 100
13.1.6 Business Strategy...................................................................................................... 100
13.1.7 Management Change................................................................................................ 101
13.1.8 ITALFARMACO S.p.A S.W.O.T Analysis...................................................................... 101
13.1.9 COVID-19 Impact Analysis......................................................................................... 101
13.2 FibroGen Inc.............................................................................................................102
13.3 Summit Therapeutics plc ..........................................................................................102
13.4 PTC Therapeutics......................................................................................................102
13.5 Santhera Pharmaceuticals ........................................................................................102
13.6 Sarepta Therapeutics Inc. .........................................................................................102
13.7 Others......................................................................................................................102
Note: Company Revenue Information Will Be Provided Subject to Data Availability! ................102
(%) by Region (2018 - 2030) ......................................................................................104

10
15.1 North America Duchenne Muscular Dystrophy Treatment Market by Country,
(2018-2030)..............................................................................................................105
15.2 North America Duchenne Muscular Dystrophy Treatment Market Size (2018-
2030) .......................................................................................................................105
15.3 North America Duchenne Muscular Dystrophy Treatment Market Y-o-Y Growth
Projection by Country (2023-2030)............................................................................106
15.3.1 North America Duchenne Muscular Dystrophy Treatment Market Revenue
(USD Million) Size by Product Type (2018-2030) ....................................................... 107
15.3.2 North America Duchenne Muscular Dystrophy Treatment Market Size by
Product Type 2022 and 2030..................................................................................... 107
(USD Million) Size by Distribution Channel (2018-2030)............................................ 108
Hospital Pharmacies 2022 and 2030 ......................................................................... 108
(USD Million) Size by Therapy (2018-2030) ............................................................... 109
Therapy 2022 and 2030............................................................................................. 109
15.4 United States ...........................................................................................................110
15.4.1 United States Duchenne Muscular Dystrophy Treatment Market Revenue
15.4.2 United States Duchenne Muscular Dystrophy Treatment Market Share by
Product Type in 2022 ................................................................................................ 110
Distribution Channel in 2022..................................................................................... 111
Therapy in 2022 ........................................................................................................ 112
15.5 Canada.....................................................................................................................113
15.5.1 Canada Duchenne Muscular Dystrophy Treatment Market Revenue (USD
Million) Size by Product Type (2018-2030)................................................................ 113
15.5.2 Canada Duchenne Muscular Dystrophy Treatment Market Share % by Product
Type in 2022 ............................................................................................................. 113
Million) Size by Distribution Channel (2018-2030) .................................................... 114

11
15.5.4 Canada Duchenne Muscular Dystrophy Treatment Market Share % by
Hospital Pharmacies in 2022..................................................................................... 114
Million) Size by Therapy (2018-2030)........................................................................ 115
15.5.6 Canada Duchenne Muscular Dystrophy Treatment Market Share % by
Therapy in 2022 ........................................................................................................ 115
15.6 Mexico.....................................................................................................................116
15.6.1 Mexico Duchenne Muscular Dystrophy Treatment Market Revenue (USD
15.6.2 Mexico Duchenne Muscular Dystrophy Treatment Market Share by Product
Type in 2022 ............................................................................................................. 116
15.6.4 Mexico Duchenne Muscular Dystrophy Treatment Market Share by Hospital
Pharmacies in 2022................................................................................................... 117
15.6.6 Mexico Duchenne Muscular Dystrophy Treatment Market Share by Therapy
in 2022...................................................................................................................... 118
16.1 Europe Duchenne Muscular Dystrophy Treatment Market by Country, (2018-
2030) .......................................................................................................................119
16.2 Europe Duchenne Muscular Dystrophy Treatment Market Size (2018-2030) ..............120
16.3 Europe Duchenne Muscular Dystrophy Treatment Market Y-o-Y Growth
16.3.1 Europe Duchenne Muscular Dystrophy Treatment Market Revenue (USD
16.3.2 Europe Duchenne Muscular Dystrophy Treatment Market Size by Product
Type 2022 and 2030.................................................................................................. 121
16.3.4 Europe Duchenne Muscular Dystrophy Treatment Market Size by Hospital
Pharmacies 2022 and 2030 ....................................................................................... 122
16.3.6 Europe Duchenne Muscular Dystrophy Treatment Market Size by Therapy
2022 and 2030 .......................................................................................................... 123
16.4 United Kingdom .......................................................................................................124

12
16.4.1 United Kingdom Duchenne Muscular Dystrophy Treatment Market Revenue
and Share by Product Type (2018-2030).................................................................... 124
and Share by Distribution Channel (2018-2030)........................................................ 124
and Share by Therapy (2018-2030) ........................................................................... 124
16.5 France......................................................................................................................124
16.5.1 France Duchenne Muscular Dystrophy Treatment Market Revenue and Share
by Product Type (2018-2030) .................................................................................... 124
by Distribution Channel (2018-2030) ........................................................................ 124
by Therapy (2018-2030) ............................................................................................ 124
16.6 Germany..................................................................................................................124
16.6.1 Germany Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Product Type (2018-2030) .......................................................................... 124
Share by Distribution Channel (2018-2030)............................................................... 124
Share by Therapy (2018-2030) .................................................................................. 124
16.7 Italy .........................................................................................................................124
16.7.1 Italy Duchenne Muscular Dystrophy Treatment Market Revenue and Share by
Product Type (2018-2030)......................................................................................... 124
Distribution Channel (2018-2030) ............................................................................. 124
Therapy (2018-2030)................................................................................................. 125
16.8 Russia ......................................................................................................................125
16.8.1 Russia Duchenne Muscular Dystrophy Treatment Market Revenue and Share
by Product Type (2018-2030) .................................................................................... 125
by Therapy (2018-2030) ............................................................................................ 125
16.9 Spain........................................................................................................................125
16.9.1 Spain Duchenne Muscular Dystrophy Treatment Market Revenue and Share
by Product Type (2018-2030) .................................................................................... 125

13
by Therapy (2018-2030) ............................................................................................ 125
16.10 Sweden....................................................................................................................125
16.10.1 Sweden Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 125
16.11 Denmark..................................................................................................................125
16.11.1 Denmark Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 126
16.12 Netherlands .............................................................................................................126
16.12.1 Netherlands Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 126
16.13 Switzerland..............................................................................................................126
16.13.1 Switzerland Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 126
16.14 Belgium....................................................................................................................127
16.14.1 Belgium Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 127
16.15 Rest of Europe..........................................................................................................127
16.15.1 Rest of Europe Duchenne Muscular Dystrophy Treatment Market Revenue

14
17.1 Asia Pacific Duchenne Muscular Dystrophy Treatment Market by Country,
(2018-2030)..............................................................................................................128
17.2 Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size (2018-2030) ........129
17.3 Asia Pacific Duchenne Muscular Dystrophy Treatment Market Y-o-Y Growth
17.3.1 Asia Pacific Duchenne Muscular Dystrophy Treatment Market Revenue (USD
17.3.2 Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size by Product
Type 2022 and 2030.................................................................................................. 130
17.3.4 Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size by Hospital
Pharmacies 2022 and 2030 ....................................................................................... 131
17.3.6 Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size by Therapy
2022 and 2030 .......................................................................................................... 132
17.4 China .......................................................................................................................133
17.4.1 China Duchenne Muscular Dystrophy Treatment Market Revenue and Share
by Product Type (2018-2030) .................................................................................... 133
by Therapy (2018-2030) ............................................................................................ 133
17.5 Japan .......................................................................................................................133
17.5.1 Japan Duchenne Muscular Dystrophy Treatment Market Revenue and Share
by Product Type (2018-2030) .................................................................................... 133
by Therapy (2018-2030) ............................................................................................ 133
17.6 Korea.......................................................................................................................133

15
17.6.1 Korea Duchenne Muscular Dystrophy Treatment Market Revenue and Share
by Product Type (2018-2030) .................................................................................... 133
by Therapy (2018-2030) ............................................................................................ 133
17.7 India ........................................................................................................................133
17.7.1 India Duchenne Muscular Dystrophy Treatment Market Revenue and Share
by Product Type (2018-2030) .................................................................................... 133
by Therapy (2018-2030) ............................................................................................ 134
17.8 Australia ..................................................................................................................134
17.8.1 Australia Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 134
17.9 Philippines ...............................................................................................................134
17.9.1 Philippines Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 134
17.10 Singapore.................................................................................................................134
17.10.1 Singapore Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 134
17.11 Malaysia ..................................................................................................................134
17.11.1 Malaysia Duchenne Muscular Dystrophy Treatment Market Revenue and

16
Share by Therapy (2018-2030) .................................................................................. 135
17.12 Thailand...................................................................................................................135
17.12.1 Thailand Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 135
17.13 Indonesia.................................................................................................................135
17.13.1 Indonesia Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 135
17.14 Rest of APAC ............................................................................................................135
17.14.1 Rest of APAC Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 135
18.1 South America Duchenne Muscular Dystrophy Treatment Market by Country,
(2018-2030)..............................................................................................................136
18.2 South America Duchenne Muscular Dystrophy Treatment Market Size (2018-
2030) .......................................................................................................................136
18.3 South America Duchenne Muscular Dystrophy Treatment Market Y-o-Y Growth
18.3.1 South America Duchenne Muscular Dystrophy Treatment Market Revenue
18.3.2 South America Duchenne Muscular Dystrophy Treatment Market Size by
Product Type 2022 and 2030..................................................................................... 138
Hospital Pharmacies 2022 and 2030 ......................................................................... 139

17
Therapy 2022 and 2030............................................................................................. 140
18.4 Brazil .......................................................................................................................141
18.4.1 Brazil Duchenne Muscular Dystrophy Treatment Market Revenue and Share
by Product Type (2018-2030) .................................................................................... 141
by Therapy (2018-2030) ............................................................................................ 141
18.5 Argentina.................................................................................................................141
18.5.1 Argentina Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 141
18.6 Colombia .................................................................................................................141
18.6.1 Colombia Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 142
18.7 Peru.........................................................................................................................142
18.7.1 Peru Duchenne Muscular Dystrophy Treatment Market Revenue and Share by
Product Type (2018-2030)......................................................................................... 142
Therapy (2018-2030)................................................................................................. 142
18.8 Chile ........................................................................................................................142
18.8.1 Chile Duchenne Muscular Dystrophy Treatment Market Revenue and Share
by Product Type (2018-2030) .................................................................................... 142
by Therapy (2018-2030) ............................................................................................ 142
18.9 Rest of South America ..............................................................................................142

18
18.9.1 Rest of South America Duchenne Muscular Dystrophy Treatment Market
Revenue and Share by Product Type (2018-2030)..................................................... 142
Revenue and Share by Distribution Channel (2018-2030) ......................................... 142
Revenue and Share by Therapy (2018-2030)............................................................. 142
19.1 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market by
Country, (2018-2030)................................................................................................143
19.2 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market Size
(2018-2030)..............................................................................................................143
19.3 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market Y-o-Y
Growth Projection by Country (2023-2030) ...............................................................144
19.3.1 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market
Revenue (USD Million) Size by Product Type (2018-2030)......................................... 145
19.3.2 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market Size
by Product Type 2022 and 2030................................................................................ 145
Revenue (USD Million) Size by Distribution Channel (2018-2030) ............................. 146
by Hospital Pharmacies 2022 and 2030..................................................................... 146
Revenue (USD Million) Size by Therapy (2018-2030)................................................. 147
by Therapy 2022 and 2030........................................................................................ 147
19.4 Saudi Arabia.............................................................................................................148
19.4.1 Saudi Arabia Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 148
19.5 Turkey .....................................................................................................................148
19.5.1 Turkey Duchenne Muscular Dystrophy Treatment Market Revenue and Share
by Product Type (2018-2030) .................................................................................... 148
by Therapy (2018-2030) ............................................................................................ 148

19
19.6 Nigeria.....................................................................................................................149
19.6.1 Nigeria Duchenne Muscular Dystrophy Treatment Market Revenue and Share
by Product Type (2018-2030) .................................................................................... 149
by Therapy (2018-2030) ............................................................................................ 149
19.7 UAE..........................................................................................................................149
19.7.1 UAE Duchenne Muscular Dystrophy Treatment Market Revenue and Share by
Product Type (2018-2030)......................................................................................... 149
Therapy (2018-2030)................................................................................................. 149
19.8 Egypt .......................................................................................................................149
19.8.1 Egypt Duchenne Muscular Dystrophy Treatment Market Revenue and Share
by Product Type (2018-2030) .................................................................................... 149
by Therapy (2018-2030) ............................................................................................ 149
19.9 South Africa .............................................................................................................150
19.9.1 South Africa Duchenne Muscular Dystrophy Treatment Market Revenue and
Share by Therapy (2018-2030) .................................................................................. 150
19.10 GCC Countries ..........................................................................................................150
19.10.1 GCC Countries Duchenne Muscular Dystrophy Treatment Market Revenue
19.11 Rest of MEA .............................................................................................................150
19.11.1 Rest of MEA Duchenne Muscular Dystrophy Treatment Market Revenue and

20
Share by Therapy (2018-2030) .................................................................................. 150
20.1 Key Takeaways.........................................................................................................151
20.2 Analyst Point of View ...............................................................................................151

21
FIG. 1 Primary Research Method 27
FIG. 2 Market Research Process 28
FIG. 3 Source of Secondary Research 29
FIG. 4 Top-Down Method 30
FIG. 5 Bottom-Up Method 30
FIG. 6 Data Triangulation 31
FIG. 7 Global Duchenne Muscular Dystrophy Treatment Market, 2018 – 2030, (USD Million) 37
FIG. 8 Global Duchenne Muscular Dystrophy Treatment Value, Absolute & Opportunity Analysis 37
FIG. 9 Global Duchenne Muscular Dystrophy Treatment Market, Y-o-Y Growth Projection (2023-2030) 38
FIG. 10 Global Duchenne Muscular Dystrophy Treatment Revenue Market Share (%) by Regions in 2018,
2022, 2030 42
FIG. 11 North America Duchenne Muscular Dystrophy Treatment Revenue (USD Million) and Growth Rate
(2018-2030) 43
FIG. 12 North America Duchenne Muscular Dystrophy Treatment Value, Absolute & Opportunity Analysis 43
FIG. 13 Europe Duchenne Muscular Dystrophy Treatment Revenue (USD Million) and Growth Rate (2018-
2030) 44
FIG. 14 Europe Duchenne Muscular Dystrophy Treatment Value, Absolute & Opportunity Analysis 44
FIG. 15 Asia Pacific Duchenne Muscular Dystrophy Treatment Revenue (USD Million) and Growth Rate (2018-
2030) 45
FIG. 16 Asia Pacific Duchenne Muscular Dystrophy Treatment Value, Absolute & Opportunity Analysis 45
FIG. 17 Latin America Duchenne Muscular Dystrophy Treatment Revenue (USD Million) and Growth Rate
(2018-2030) 46
FIG. 18 Latin America Duchenne Muscular Dystrophy Treatment Value, Absolute & Opportunity Analysis 46
FIG. 19 Middle East and Africa Duchenne Muscular Dystrophy Treatment Revenue (USD Million) and Growth
Rate (2018-2030) 47
FIG. 20 Middle East and Africa Duchenne Muscular Dystrophy Treatment Value, Absolute & Opportunity
Analysis 47
FIG. 21 Global Duchenne Muscular Dystrophy Treatment Revenue (USD Million) Status and Outlook (2018-
2030) 48
FIG. 22 Global Duchenne Muscular Dystrophy Treatment Revenue Share by Manufacturers 50
FIG. 23 Top Winning Strategies, by Manufacturers (2018-2022) 53
FIG. 24 Overall Company’s Disclosure Score 54
FIG. 25 Global Duchenne Muscular Dystrophy Treatment Market – PESTEL Analysis 62
FIG. 26 Porter’s Five Forces Analysis 64
FIG. 27 Power of Suppliers 65
FIG. 28 Threat of Substitutes 66
FIG. 29 Potential of New Entrants into an Industry 67
FIG. 30 Power of Customers 68
FIG. 31 Competition in the Industry 69
FIG. 32 Product Life Cycle 70
FIG. 33 Market Attractiveness Analysis by Product Type Segment 71
FIG. 34 Market Attractiveness Analysis by Application Segment 72
FIG. 35 2022 Revenue Market Share (%) of Duchenne Muscular Dystrophy Treatment by Product Type 74
FIG. 36 Global NSAIDs Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 75
FIG. 37 Global NSAIDs Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 75
FIG. 38 Duchenne Muscular Dystrophy Treatment Market for NSAIDs, by Country (2021 Vs 2024) 76
FIG. 39 Global Corticosteroids Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 77
FIG. 40 Global Corticosteroids Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 77

22
FIG. 41 Duchenne Muscular Dystrophy Treatment Market for Corticosteroids, by Country (2021 Vs 2024) 78
FIG. 42 Global Other Products Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 79
FIG. 43 Global Other Products Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 79
FIG. 44 Duchenne Muscular Dystrophy Treatment Market for Other Products, by Country (2021 Vs 2024) 80
FIG. 45 2022 Revenue Market Share (%) of Duchenne Muscular Dystrophy Treatment by Distribution Channel 81
FIG. 46 Global Distribution Channel Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 82
FIG. 47 Global Hospital Pharmacies Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 82
FIG. 48 Duchenne Muscular Dystrophy Treatment Market for Distribution Channel, by Country (2021 Vs 2024) 83
FIG. 49 Global Retail Pharmacies Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 84
FIG. 50 Global Retail Pharmacies Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 84
FIG. 51 Duchenne Muscular Dystrophy Treatment Market for Retail Pharmacies, by Country (2021 Vs 2024) 85
FIG. 52 Global Online Pharmacies Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 86
FIG. 53 Global Online Pharmacies Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 86
FIG. 54 Duchenne Muscular Dystrophy Treatment Market for Retail Pharmacies, by Country (2021 Vs 2024) 87
FIG. 55 2022 Revenue Market Share (%) of Duchenne Muscular Dystrophy Treatment by Therapy 88
FIG. 56 Global Mutation Suppression Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 89
FIG. 57 Global Mutation Suppression Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 89
FIG. 58 Duchenne Muscular Dystrophy Treatment Market for Mutation Suppression, by Country (2021 Vs 2024) 90
FIG. 59 Global Exon Skipping Approach Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 91
FIG. 60 Global Exon Skipping Approach Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 91
FIG. 61 Duchenne Muscular Dystrophy Treatment Market for Exon Skipping Approach, by Country (2021 Vs
2024) 92
FIG. 62 Global Others Therapies Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 93
FIG. 63 Global Others Therapies Market Revenue (USD Million) and Growth Rate (%), (2018 – 2030) 93
FIG. 64 Duchenne Muscular Dystrophy Treatment Market for Others Therapies, by Country (2021 Vs 2024) 94
FIG. 65 ITALFARMACO S.p.A Revenue Market Share (%) (2018-2022) 98
FIG. 66 ITALFARMACO S.p.A R&D Investment (USD Million) (2021-2020) 99
FIG. 67 ITALFARMACO S.p.A Net Sales, By Segments (2020-2021) (USD Million) 99
FIG. 68 ITALFARMACO S.p.A Net Sales, By Region (2020-2021) 100
FIG. 69 2018, 2022 and 2030 Revenue Market Share (%) of Duchenne Muscular Dystrophy Treatment by
Region 104
FIG. 70 North America Duchenne Muscular Dystrophy Treatment Market Share (%) by Country (2018-2030) 105
FIG. 71 North America Duchenne Muscular Dystrophy Treatment Market Y-o-Y Growth Projection 106
FIG. 72 North America Duchenne Muscular Dystrophy Treatment Market Size by Product Type 2022 and 2030 107
FIG. 73 North America Duchenne Muscular Dystrophy Treatment Market Size by Hospital Pharmacies 2022
and 2030 108
FIG. 74 North America Duchenne Muscular Dystrophy Treatment Market Size by Therapy 2022 and 2030 109
FIG. 75 United States Duchenne Muscular Dystrophy Treatment Market Share % by Product Type in 2022 110
FIG. 76 United States Duchenne Muscular Dystrophy Treatment Market Share % by Distribution Channel in
2022 111
FIG. 77 United States Duchenne Muscular Dystrophy Treatment Market Share % by Therapy in 2022 112
FIG. 78 Canada Duchenne Muscular Dystrophy Treatment Market Share % by Product Type in 2022 113
FIG. 79 Canada Duchenne Muscular Dystrophy Treatment Market Share % by Distribution Channel in 2022 114
FIG. 80 Canada Duchenne Muscular Dystrophy Treatment Market Share % by Therapy in 2022 115
FIG. 81 Mexico Duchenne Muscular Dystrophy Treatment Market Share % by Product Type in 2022 116
FIG. 82 Mexico Duchenne Muscular Dystrophy Treatment Market Share % by Distribution Channel in 2022 117
FIG. 83 Mexico Duchenne Muscular Dystrophy Treatment Market Share % by Therapy in 2022 118
FIG. 84 Europe Duchenne Muscular Dystrophy Treatment Market Share (%) by Country (2018-2030) 120
FIG. 85 Europe Duchenne Muscular Dystrophy Treatment Market Y-o-Y Growth Projection 120

23
FIG. 86 Europe Duchenne Muscular Dystrophy Treatment Market Size by Product Type 2022 and 2030 121
FIG. 87 Europe Duchenne Muscular Dystrophy Treatment Market Size by Hospital Pharmacies 2022 and 2030 122
FIG. 88 Europe Duchenne Muscular Dystrophy Treatment Market Size by Therapy 2022 and 2030 123
FIG. 89 Asia Pacific Duchenne Muscular Dystrophy Treatment Market Share (%) by Country (2018-2030) 129
FIG. 90 Asia Pacific Duchenne Muscular Dystrophy Treatment Market Y-o-Y Growth Projection 129
FIG. 91 Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size by Product Type 2022 and 2030 130
FIG. 92 Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size by Hospital Pharmacies 2022 and
2030 131
FIG. 93 Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size by Therapy 2022 and 2030 132
FIG. 94 South America Duchenne Muscular Dystrophy Treatment Market Share (%) by Country (2018-2030) 136
FIG. 95 South America Duchenne Muscular Dystrophy Treatment Market Y-o-Y Growth Projection 137
FIG. 96 South America Duchenne Muscular Dystrophy Treatment Market Size by Product Type 2022 and 2030 138
FIG. 97 South America Duchenne Muscular Dystrophy Treatment Market Size by Hospital Pharmacies 2022
and 2030 139
FIG. 98 South America Duchenne Muscular Dystrophy Treatment Market Size by Therapy 2022 and 2030 140
FIG. 99 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market Share (%) by Country (2018-
2030) 143
FIG. 100 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market Y-o-Y Growth Projection 144
FIG. 101 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market Size by Product Type 2022
and 2030 145
FIG. 102 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market Size by Distribution Channel
2022 and 2030 146
FIG. 103 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market Size by Therapy 2022 and
2030 147

24
TABLE 1 Market Snapshot 39
TABLE 2 Duchenne Muscular Dystrophy Treatment Market Revenue (USD Million) Comparison by Regions
(2018-2030) 42
TABLE 3 Global Duchenne Muscular Dystrophy Treatment Revenue (USD Million) by Manufacturers (2018-2022)49
TABLE 4 Global Duchenne Muscular Dystrophy Treatment Revenue Share by Manufacturers (2018-2022) 50
TABLE 5 Global Duchenne Muscular Dystrophy Treatment Market: Market Evaluation Framework 51
TABLE 6 Drivers For Duchenne Muscular Dystrophy Treatment Market: Impact Analysis 58
TABLE 7 Restraints For Duchenne Muscular Dystrophy Treatment Market: Impact Analysis 59
TABLE 8 Global Duchenne Muscular Dystrophy Treatment Revenue (USD Million) by Product Type (2018-2030) 74
TABLE 9 Global Duchenne Muscular Dystrophy Treatment Revenue Share (%) by Product Type (2018-2030) 74
TABLE 10 Global Duchenne Muscular Dystrophy Treatment Revenue (USD Million) by Distribution Channel
(2018-2030) 81
TABLE 11 Global Duchenne Muscular Dystrophy Treatment Revenue Share (%) by Distribution Channel (2018-
2030) 81
TABLE 12 Global Duchenne Muscular Dystrophy Treatment Revenue (USD Million) by Therapy (2018-2030) 88
TABLE 13 Global Duchenne Muscular Dystrophy Treatment Revenue Share (%) by Therapy (2018-2030) 88
TABLE 14 ITALFARMACO S.p.A Basic Information, Manufacturing Base, Sales Area and Its Competitors 96
TABLE 15 ITALFARMACO S.p.A Revenue (USD Million), Gross Margin (%) and Market Share (%) (2018-2022) 98
TABLE 16 Global Duchenne Muscular Dystrophy Treatment Revenue (USD Million) by Region (2018- 2030) 104
TABLE 17 North America Duchenne Muscular Dystrophy Treatment Market by Country Revenue, 2018-2030 105
TABLE 18 North America Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Product Type
(2018-2030) 107
TABLE 19 North America Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Distribution
Channel (2018-2030) 108
TABLE 20 North America Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Therapy (2018-
2030) 109
TABLE 21 United States Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Product Type
(2018-2030) 110
TABLE 22 United States Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Distribution
Channel (2018-2030) 111
TABLE 23 United States Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Therapy (2018-
2030) 112
TABLE 24 Canada Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Product Type (2018-
2030) 113
TABLE 25 Canada Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Distribution Channel
(2018-2030) 114
TABLE 26 Canada Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Therapy (2018-2030) 115
TABLE 27 Mexico Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Product Type (2018-
2030) 116
TABLE 28 Mexico Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Distribution Channel
(2018-2030) 117
TABLE 29 Mexico Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Therapy (2018-2030) 118
TABLE 30 Europe Duchenne Muscular Dystrophy Treatment Market by Country Revenue, 2018-2030 119
TABLE 31 Europe Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Product Type (2018-
2030) 121
TABLE 32 Europe Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Distribution Channel
(2018-2030) 122
TABLE 33 Europe Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Therapy (2018-2030) 123
TABLE 34 Asia Pacific Duchenne Muscular Dystrophy Treatment Market by Country Revenue, 2018-2030 128

25
TABLE 35 Asia Pacific Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Product Type
(2018-2030) 130
TABLE 36 Asia Pacific Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Distribution
Channel (2018-2030) 131
TABLE 37 Asia Pacific Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Therapy (2018-
2030) 132
TABLE 38 South America Duchenne Muscular Dystrophy Treatment Market by Country Revenue, 2018-2030 136
TABLE 39 South America Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Product Type
(2018-2030) 138
TABLE 40 South America Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Distribution
Channel (2018-2030) 139
TABLE 41 South America Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Therapy (2018-
2030) 140
TABLE 42 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market by Country Revenue, 2018-
2030 143
TABLE 43 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Product
Type (2018-2030) 145
TABLE 44 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by
Distribution Channel (2018-2030) 146
TABLE 45 Middle East and Africa Duchenne Muscular Dystrophy Treatment Market (USD Million) Size by Therapy
(2018-2030) 147

26
1.1 Research Methodology
Our research involves the extensive use of both primary and secondary data sources for market surveys, estimates, and analyzing
forecasts. The report is based on an in-depth qualitative and quantitative analysis of the Duchenne Muscular Dystrophy
Treatment Market. We at CMR tend to draw on various study methods, including investigations, surveys, secondary data, and
market observation. Our approach helps build a better market consensus view for size, shape, and industry trends within each
segment. We carefully factor in industry trends and actual developments for identifying key growth factors and the future course
of the market. The gathered data has been interpreted and analyzed to provide a conclusion.
The complete process involves the study of various factors, such as market scenarios, government policies, competitive
environment, historical data, current trends, technological advancements, and progress in related industries, along with threats
and challenges.

27
1.1.1 Primary Research
The primary research involves sources from the entire value chain, i.e., from supply to demand side players. The efforts include
contacting participants through emails, telephonic conversations, referrals, professional networks, and formal interactions. These
players were interviewed to obtain qualitative and quantitative information regarding the Duchenne Muscular Dystrophy
Treatment Market. Primarily, the interviews were conducted to design the scope of the report to identify segment analysis.
Our primary research interviews and discussion panel comprises vital opinion leaders, industry experts, manufacturers, and
organizations. We have pooled these experts to gather first-hand insights into the market studied. Moreover, market surveys
were performed to get insights into market trends and competitive analysis. Primary research was conducted to validate data
that had been gained by doing secondary research and to fill the data gaps after the secondary research process.
Thus, the primary research study helps us to identify segmentation Product Types, product Distribution Channel, product
applications, major players involved, raw material suppliers, downstream demand, industry status, and outlook. We analyze
respective risks, influence factors, opportunities, market barriers, industry trends, and key player strategies associated with
Duchenne Muscular Dystrophy Treatment Market by performing primaries with an exhaustive list of participants.
FIG. 1 Primary Research Method
Extensive Primary Research Helps Us to:
• Validate data findings and strengthens research proceeds
• Develop an in-depth market understanding
• Supply authentic information about market size, share breakdown, growth, and forecast

28
1.1.2 Modes of Primary Research:
We have conducted primary research involving direct interaction with the source, usually a customer or prospective customer.
Methods used while doing primary research includes Interviews, Surveys, Focus Group, etc.
FIG. 2 Market Research Process
1.2 Secondary Research Methodology:
In secondary research, we collect data on the global Duchenne Muscular Dystrophy Treatment market through White Papers,
Case Studies, Blogs, Reference Clients, News, Articles, Press Releases, Research Reports, Annual Reports, Company Investor
Presentations, Scientific Journals, National Customs, Industry Associations, and the company's filings with the SEC. Sources and
approaches differ from market to market and product to product. We also have paid data sources like Hoovers, Bloomberg
BusinessWeek, Factiva (Dow Jones), Statista, Reuters, One Source, and more. After conducting secondary research, we conduct
primary research by interacting with industry experts such as VPs, product managers, and various industry consultants. The
number of interviews conducted depends on market size and the availability of market recovery data.
Based on the understanding of requirements, we conducted secondary research to identify the segment specifications and
qualitative and quantitative data along with the factors responsible for the growth of the global Duchenne Muscular Dystrophy
Treatment market. Moreover, quantitative and qualitative data were also extracted from paid databases, which proved to be
useful for in-depth technical study of the market. Secondary research is used to identify and collect information useful for the
extensive, technical, market-oriented, and table tops survey of the market. It was used to obtain important information about
the top companies, market classification, and segmentation according to industry trends to the bottom-most levels, and key
developments related to market and technology perspectives. Secondary research has mainly been applied to obtain critical
information about the industry’s supply chain, the market downstream buyers, technical dynamics development trends.
Furthermore, it also helps to gain insight on the key vendors of this market, and market classification & segmentation according
to the industry trends, regional markets, and key developments from a market and business-oriented perspective.

29
FIG. 3 Source of Secondary Research
1.3 Market Estimation
Top-down and bottom-up approaches have been implemented to validate the Duchenne Muscular Dystrophy Treatment market
size estimation. The market estimations in this report are based on the marketed sale price of products. The percentage
breakdown of regions and segments are derived based on the data gathered from primary and secondary sources, based upon
the weightage assigned to the individual segment.
The competitive scenario has been understood by identifying major players involved in the market. The company's revenue for
the Duchenne Muscular Dystrophy Treatment market has been estimated through secondary and validated through primary
research. We have done the company's secondary research through annual reports, news articles, and other trusted sources.
Primary research included interviews of key opinion leaders and industry experts such as experienced front-line staff, directors,
CEOs, and marketing executives.
This research studies includes all the associated factors impacting market growth. This data is combined and added with detailed
inputs and analysis, which is presented in this report.

30
1.3.1 Top-Down Method
FIG. 4 Top-Down Method
1.3.2 Bottom-Up Method
FIG. 5 Bottom-Up Method

31
1.3.3 Data Triangulation
After completing market engineering with calculations for market statistics, market size estimations, market forecasting, market
breakdown, and other data gathering, extensive primary research was conducted to gather information and verify and validate
the critical numbers arrived at. The data was triangulated by studying various factors and trends from both, the demand and
supply sides. Along with this, the market size was validated using the top-down and bottom-up approach.
FIG. 6 Data Triangulation

32
1.4 Questionnaire
At Cognitive Market Research, we have designed questionnaire focused on Duchenne Muscular Dystrophy Treatment Market for
the statistical study. This questionnaire is the key part of our research methodology which is shared with number of Duchenne
Muscular Dystrophy Treatment industry experts of entire value chain, located across the globe. This study help us to gather
accurate quantitative and qualitative data for the final report.

33
2.1 Global Duchenne Muscular Dystrophy Treatment Industry Introduction

34
2.2 Objectives of the Study
• Our objective for the Duchenne Muscular Dystrophy Treatment market is to help in making imperative business
decisions, securing investments, determining new business opportunities in the market. Further, the report helps to
analyze overall marketing needs of customers, and avoiding business failures
• To know the potential market size and growth rate before launching a new product line. The report in a way help in
designing R&D budget wisely by estimating maximum total profit
• To identify the Duchenne Muscular Dystrophy Treatment market dynamics, industrial insights, and economic
progression for critical information about the market conditions and specific business landscape
• To assess the overall competitive landscape of a particular business sector and to provide complete analysis in regards
with various external factors impacting the market growth
• To create a strong foundation for building a strategy and foster insight into market conditions so that market players
can make better business decisions. Besides, our aim is to provide complete portfolio of the major players involved the
market
• To define the scope which will further help in creating new products that will surpass the gap between current offerings
and customers’ needs
• To help in revealing significant clues concerning buying habits, regional culture, lifestyle, and population density that
plays an integral role in shaping market behavior
• To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the
total market.
2.3 USP of the Report
Cognitive market research is a market research, analysis and solutions focused company that provides clients with strategic and
tactical support to draw informed business conclusions. We are a dedicated and enthusiastic group of people who firmly believe
in doing our best in what we do, and we never back down from any challenge.
Cognitive Market Research provides coverage, analysis, information, statistics and reports on global and regional markets,
industries, sectors and domains including pharmaceuticals, chemicals and materials, technology and media, food and beverages,
packaging and consumer and other industries. We provide a 360-degree view of the market and provide accurate forecasts, and
also cover the competitive landscape, providing detailed market segmentation, key trends and strategic recommendations to
keep our clients ahead of the competition.
We broadly categorize our products into custom market research and syndicated market research reports. A syndicated research
report covers data, information and analysis on a subject or subject that may benefit one or more businesses or individuals. Topics
or headlines may vary by macro industry or micro market level. We offer unique report titles which cover the entire landscape of
the specific industry from a host of industry verticals.

35
2.4 Who is this report for?
The research study and report are been made exclusively for an institution or person who is strategizing to build a business or
strategically wants to expand certain portfolio. This report will help in analyzing complete market scenario across the globe who
wish to expand its current business or is willing to invest in some profitable sector. This report will prove beneficial for person or
an organization who wish to be updated regarding their business environment, consumers’ behaviour, and their requirements.
The environment is constantly changing, in such scenario this report will help in understanding market parameters through 360-
degree view.
The report is thus ideal for KOL, CEO's, CFO's, directors, and others. It is also helpful to senior executives, business development
managers, marketing managers, and consultants. Furthermore, government bodies, agencies and other kind of organizations can
also leverage our report to understand market.
2.5 Regional Fragmentation
NA:
➢ U.S., Canada, Mexico
EU:
➢ Germany, UK, Italy, France, Spain, Switzerland, Sweden, Rest of EU
APAC:
➢ China, Japan, India, South Korea, Australia, Philippines, Vietnam, Malaysia, Rest of APAC
LA:
➢ Brazil, Chile, Argentina, Colombia, Peru, Rest of Latin America
MEA:
➢ Saudi Arabia, UAE, Egypt, South Africa, Iraq, Kuwait, Morocco, Others

36
2.6 Report Duration
Note: *The complete report is been projected in USD Dollars. In the process of analysis, findings from other currency is been
converted to USD Dollars
**All the estimations in terms of volume and revenue are presented in Units and USD Million respectively.
2.7 List of Stakeholders
➢ Raw material suppliers
➢ Manufacturers and Distributors
➢ OEM’s
➢ Government and financial institutions
➢ Technology investors
➢ Venture capitalists
➢ Associations, organizations, forums, and alliances
➢ End-users
2023-2030
2022
2018-2022

37
3.1 Global Duchenne Muscular Dystrophy Treatment Market, 2018 – 2030, (USD Million)
The Global Duchenne Muscular Dystrophy Treatment Market is valued at USD XX Million in 2018 and is expected to reach USD
XX Million by the end of 2030, growing at a CAGR of XX% between 2023 and 2030.
FIG. 7 Global Duchenne Muscular Dystrophy Treatment Market, 2018 – 2030, (USD Million)
Source: Cognitive Market Research
3.2 Global Duchenne Muscular Dystrophy Treatment Value, Absolute & Opportunity Analysis
FIG. 8 Global Duchenne Muscular Dystrophy Treatment Value, Absolute & Opportunity
Analysis

38
3.3 Global Duchenne Muscular Dystrophy Treatment Market Y-o-Y Growth Projection by Region
(2023 - 2030)
FIG. 9 Global Duchenne Muscular Dystrophy Treatment Market, Y-o-Y Growth Projection
(2023-2030)

39
3.4 Global Duchenne Muscular Dystrophy Treatment Market: Snapshot
TABLE 1 Market Snapshot
Duchenne
Muscular
Dystrophy
Treatment
Market
2018 2022 2030
Global
Revenue (USD
Million)
xx xx xx
CAGR (2023 –
2030)
xx%
Key Product
Type Segment
(Revenue
Share)
NSAIDs:xx%
Corticosteroids:xx%
Other Products:xx%
NSAIDs:xx%
Corticosteroids:xx%
Other Products:xx%
NSAIDs:xx%
Corticosteroids:xx%
Other Products:xx%
Key
Distribution
Channel
Segment
(Revenue
Share)
Hospital Pharmacies:xx%
Retail Pharmacies:xx%
Online Pharmacies:xx%
Key Therapy
Segment
(Revenue
Share)
Mutation Suppression:xx%
Exon Skipping Approach:xx%
Others Therapies:xx%
Key Regional
Segment
(Revenue
Share)
North America: xx%
Europe: xx%
Asia Pacific: xx%
Latin America: xx%
Middle East and Africa: xx%
North America: xx%
Europe: xx%
Asia Pacific: xx%
Latin America: xx%
North America: xx%
Europe: xx%
Asia Pacific: xx%
Latin America: xx%
Driver

40
Restraint
Opportunity
Trend

41
4.1 Product Overview and Scope of Duchenne Muscular Dystrophy Treatment Market

42
4.2 Global Duchenne Muscular Dystrophy Treatment Revenue Market by Regions (2018-2030)
TABLE 2 Duchenne Muscular Dystrophy Treatment Market Revenue (USD Million) Comparison
by Regions (2018-2030)
Regions 2018 2022 2030 Market Share
(%)
2030
CAGR (%)
(2023-2030)
North America XX XX XX XX Xx
Europe XX XX XX XX Xx
Asia Pacific XX XX XX XX Xx
Latin America XX XX XX XX Xx
Middle East and Africa XX XX XX XX Xx
Total XX XX XX XX XX
FIG. 10 Global Duchenne Muscular Dystrophy Treatment Revenue Market Share (%) by Regions
in 2018, 2022, 2030

43
4.2.1 North America Duchenne Muscular Dystrophy Treatment Status and
Prospect (2018-2030)
The North America Duchenne Muscular Dystrophy Treatment market size was USD xx Million in 2018
and it will be USD xx Million in 2030.
FIG. 11 North America Duchenne Muscular Dystrophy Treatment Revenue (USD Million) and
Growth Rate (2018-2030)
4 . 2 . 1 . 1 N o r t h A m e r i c a D u c h e n n e M u s c u l a r D y s t r o p h y T r e a t m e n t V a l u e ,
A b s o l u t e & O p p o r t u n i t y A n a l y s i s
FIG. 12 North America Duchenne Muscular Dystrophy Treatment Value, Absolute &
Opportunity Analysis

44
4.2.2 Europe Duchenne Muscular Dystrophy Treatment Status and Prospect (2018 -
2030)
The Europe Duchenne Muscular Dystrophy Treatment market size was USD xx Million in 2018 and it will
be USD xx Million in 2030.
FIG. 13 Europe Duchenne Muscular Dystrophy Treatment Revenue (USD Million) and Growth
Rate (2018-2030)
4 . 2 . 2 . 1 E u r o p e D u c h e n n e M u s c u l a r D y s t r o p h y T r e a t m e n t V a l u e , A b s o l u t e &
O p p o r t u n i t y A n a l y s i s
FIG. 14 Europe Duchenne Muscular Dystrophy Treatment Value, Absolute & Opportunity
Analysis

45
4.2.3 Asia Pacific Duchenne Muscular Dystrophy Treatment Status and Prospect
(2018-2030)
The Asia Pacific Duchenne Muscular Dystrophy Treatment market size was USD xx Million in 2018 and it
will be USD xx Million in 2030.
FIG. 15 Asia Pacific Duchenne Muscular Dystrophy Treatment Revenue (USD Million) and
4 . 2 . 3 . 1 A s i a P a c i f i c D u c h e n n e M u s c u l a r D y s t r o p h y T r e a t m e n t V a l u e ,
FIG. 16 Asia Pacific Duchenne Muscular Dystrophy Treatment Value, Absolute & Opportunity
Analysis

46
4.2.4 Latin America Duchenne Muscular Dystrophy Treatment Status and Prospect
(2018-2030)
The Latin America Duchenne Muscular Dystrophy Treatment market size was USD xx Million in 2018 and
it will be USD xx Million in 2030.
FIG. 17 Latin America Duchenne Muscular Dystrophy Treatment Revenue (USD Million) and
4 . 2 . 4 . 1 L a t i n A m e r i c a D u c h e n n e M u s c u l a r D y s t r o p h y T r e a t m e n t V a l u e ,
FIG. 18 Latin America Duchenne Muscular Dystrophy Treatment Value, Absolute & Opportunity
Analysis

47
4.2.5 Middle East and Africa Duchenne Muscular Dystrophy Treatment Status and
Prospect (2018-2030)
The Middle East and Africa Duchenne Muscular Dystrophy Treatment market size was USD xx Million in
2018 and it will be USD xx Million in 2030.
FIG. 19 Middle East and Africa Duchenne Muscular Dystrophy Treatment Revenue (USD
Million) and Growth Rate (2018-2030)
4 . 2 . 5 . 1 M i d d l e E a s t a n d A f r i c a D u c h e n n e M u s c u l a r D y s t r o p h y T r e a t m e n t
V a l u e , A b s o l u t e & O p p o r t u n i t y A n a l y s i s
FIG. 20 Middle East and Africa Duchenne Muscular Dystrophy Treatment Value, Absolute &
Opportunity Analysis

Global Duchenne Muscular Dystrophy Treatment Market Report 2023 - Cognitive Market Research

Global Duchenne Muscular Dystrophy Treatment Market Report 2023 - Cognitive Market Research

Recommandé

Recommandé

Contenu connexe

Similaire à Global Duchenne Muscular Dystrophy Treatment Market Report 2023 - Cognitive Market Research

Similaire à Global Duchenne Muscular Dystrophy Treatment Market Report 2023 - Cognitive Market Research (12)

Plus de Cognitive Market Research

Plus de Cognitive Market Research (15)

Dernier

Dernier (20)

Global Duchenne Muscular Dystrophy Treatment Market Report 2023 - Cognitive Market Research